These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33615662)

  • 1. Proposal of Stroop test cut-off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study.
    Kondo Y; Iwasa M; Kawaratani H; Miyaaki H; Hanai T; Kon K; Hirano H; Shimizu M; Yoshiji H; Okita K; Koike K
    Hepatol Res; 2021 Jun; 51(6):674-681. PubMed ID: 33615662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of EncephalApp Stroop Test in Cirrhotic Patients for Evaluating Covert Hepatic Encephalopathy.
    Kurniawan J; Ranty SS; Sulaiman AS; Gani RA
    Acta Med Indones; 2023 Jul; 55(3):296-306. PubMed ID: 37915156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updating the neuropsychological test system in Japan for the elderly and in a modern touch screen tablet society by resetting the cut-off values.
    Kawaguchi T; Konishi M; Kato A; Kato M; Kooka Y; Sawara K; Endo R; Torimura T; Suzuki K; Takikawa Y
    Hepatol Res; 2017 Nov; 47(12):1335-1339. PubMed ID: 28066966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients.
    Hamzaoui L; Mahmoudi M; Mohamed G; Elloumi H; Laabidi A; Boubaker J; Boudabbous M; Tahri N; Jemni I; Safer L; Jomni T; Douggui H; Trad D; Gargouri D; Ayadi S; Debbeche R; Belhouchet S; Marouani R; Cheikh I; Abdelli MN
    F1000Res; 2022; 11():686. PubMed ID: 37767072
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined Scores from the EncephalApp Stroop Test, Number Connection Test B, and Serial Dotting Test Accurately Identify Patients With Covert Hepatic Encephalopathy.
    Zeng X; Zhang LY; Liu Q; Lu CH; Wei J; Shi ZW; Huang WR; Qu LH; Xu F; Wang XH; Shi PM; Tan Y; Tan W; Yuan ZL; Xia CY; Liu YL; Xie WF
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1618-1625.e7. PubMed ID: 31712074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the EncephalApp Stroop Test for covert hepatic encephalopathy screening in Chinese cirrhotic patients.
    Zeng X; Li XX; Shi PM; Zhang YY; Song Y; Liu Q; Wei L; Bajaj JS; Zhu YH; Li Y; Gu Y; Xie WF; Liu YL
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1843-1850. PubMed ID: 30861191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
    Hanai T; Nishimura K; Miwa T; Maeda T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
    J Gastroenterol; 2022 Dec; 57(12):981-989. PubMed ID: 36173512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis.
    Kaji K; Okita K; Suzuki K; Sato I; Fujisawa M; Yoshiji H
    JGH Open; 2021 Feb; 5(2):207-212. PubMed ID: 33553657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Minimal Hepatic Encephalopathy with Brain MRI and EncephalApp Stroop Test.
    Lupescu IC; Iacob S; Lupescu IG; Pietrareanu C; Gheorghe L
    Maedica (Bucur); 2023 Mar; 18(1):4-11. PubMed ID: 37266463
    [No Abstract]   [Full Text] [Related]  

  • 10. USE OF THE STROOP ENCEPHALAPP FOR COVERT HEPATIC ENCEPHALOPATHY SCREENING IN CIRRHOTIC PATIENTS IN SOUTHERN BRAZIL.
    Machado JÚnior PAB; Ziliotto RD; Ferreira APVN; Buson TM; Couto CMD; Pissaia Junior A
    Arq Gastroenterol; 2020; 57(4):399-403. PubMed ID: 33237215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Covert Hepatic Encephalopathy in A Tertiary Care Centre.
    Pathak R; Ghimire P; Thapaliya S; Sharma S; Khadga P
    JNMA J Nepal Med Assoc; 2020 Jan; 58(221):29-32. PubMed ID: 32335636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy.
    Labenz C; Beul L; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Eur J Intern Med; 2019 Feb; 60():96-100. PubMed ID: 30131209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese.
    Kato A; Kato M; Ishii H; Ichimiya Y; Suzuki K; Kawasaki H; Yamamoto SI; Kumashiro R; Yamamoto K; Kawamura N; Hayashi N; Matsuzaki S; Terano A; Okita K; Watanabe A
    Hepatol Res; 2004 Oct; 30(2):71-78. PubMed ID: 15519270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization.
    Bai Z; Guo X; Tacke F; Li Y; Li H; Qi X
    Therap Adv Gastroenterol; 2019; 12():1756284819881302. PubMed ID: 31636711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.
    Wuensch T; Ruether DF; Zöllner C; Mueller T; Jung T; Kaffarnik M; Kassner U; Schott E; Kiefer S; Pratschke J; Stockmann M; Jara M
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):456-463. PubMed ID: 28092641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study.
    Saxena N; Bhatia M; Joshi YK; Garg PK; Tandon RK
    J Gastroenterol Hepatol; 2001 Mar; 16(3):322-7. PubMed ID: 11339425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Korean Stroop Test in Diagnosis of Minimal Hepatic Encephalopathy.
    Yoon EL; Jun DW; Jeong JY; Kim TY; Song DS; Ahn SB; Kim HY; Jung YK; Song MJ; Kim SE; Kim HS; Jeong SW; Kim SG; Lee TH; Cho YK; Kim JK; Ryu H
    Sci Rep; 2019 May; 9(1):8027. PubMed ID: 31142824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal for new sleep disorder criteria in patients with chronic liver disease: Influence of liver-related complications.
    Miyaaki H; Hiraoka A; Haraguchi M; Uojima H; Kawaratani H; Hiramatsu A; Hanai T; Hiasa Y; Yoshiji H; Okita K; Nakao K; Koike K
    Hepatol Res; 2022 Apr; 52(4):364-370. PubMed ID: 34755420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal/Covert Hepatic Encephalopathy - Impact of Comorbid Conditions.
    Weissenborn K
    J Clin Exp Hepatol; 2019; 9(1):109-111. PubMed ID: 30765943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.